Another report that investigated BAL samples from COVID-19 patients demonstrated that atypical lymphocytes in BAL samples were virtually all CD3-positive T cells, and a significant proportion of T cells (40–80%) in BAL samples expressed activation markers such as CD38, HLA-DR and CD25 [6]. This evidence concerns the gene CD38 and COVID-19.